Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
JCSE01 - Joint IASLC-CSCO-CAALC Session
- 07:00 - 11:15
- 9/07/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Joint IASLC-CSCO-CAALC Session
- Track:
- Moderators:Chunxue Bai, Tony Mok, Yi-Long Wu, Qing Zhou, Nan Wu
-
+
JCSE01.26 - PD-1 Inhibitor Plus Chemotherapy as 2nd/Subsequent Line Setting Demonstrate Superior Efficacy over PD-1 Inhibitor Alone in Pts of Advanced NSCLC
10:45 - 10:45 | Presenter: Shengxiang Ren | Author(s): Yiwei Liu, Fei Zhou, Tao Jiang, Chunxia Su, Xiaoxia Chen, Caicun Zhou
- Abstract
Loading...
-
+
ES10 - Oncology Drug Approval: Challenges and Opportunities
- 13:30 - 15:00
- 9/08/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Educational Session
- Track: Advanced NSCLC
- Moderators:Caicun Zhou, Alice T. Shaw
-
+
ES10.01 - US Food and Drug Administration
13:30 - 13:45 | Presenter: Gideon M Blumenthal
- Abstract
Loading... -
+
ES10.02 - Japan Pharmaceuticals and Medical Devices Agency
13:45 - 14:00 | Presenter: Sumimasa Nagai
- Abstract
Loading... -
+
ES10.03 - China National Medical Products Administration (Formerly CFDA)
14:00 - 14:15 | Presenter: Tony Mok
- Abstract
No abstract available for this presentation
-
+
ES10.04 - European Medicines Agency
14:15 - 14:30 | Presenter: Jorge Camarero
- Abstract
Loading... -
+
ES10.05 - Brazilian Health Regulatory Agency - Agência Nacional de Vigilância Sanitária
14:30 - 14:45 | Presenter: Carlos Gil Ferreira
- Abstract
Loading... -
+
ES10.06 - Q&A
14:45 - 15:00
- Abstract
No abstract available for this presentation
-
+
MA04 - Models and Biomarkers
- 13:30 - 15:00
- 9/08/2019
- Location: Interlaken (1988)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Biology
- Moderators:Montse Sanchez-Cespedes, Kwok-kin Wong
-
+
MA04.02 - Molecular Profiling of Adenocarcinoma and Squamous Cell Lung Cancer at Single Cell Resolution
13:35 - 13:40 | Presenter: fengying Wu | Author(s): Yayi He, Zhou Yiqi, Anwen Xiong, Jia Yu, Wei Li, Nan Fang, Caicun Zhou
- Abstract
Loading...
-
+
OA04 - Immuno Combinations and the Role of TMB
- 15:15 - 16:45
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Solange Peters, Martin Reck
-
+
OA04.03 - A Randomized Phase 3 Study of Camrelizumab plus Chemotherapy as 1st Line Therapy for Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
15:35 - 15:45 | Presenter: Caicun Zhou | Author(s): Gongyan Chen, yunchao Huang, Jianying Zhou, LiZhu Lin, Jifeng Feng, Zhehai Wang, Yongqian Shu, Jianhua Shi, Yi Hu, Qiming Wang, Ying Cheng, Jianhua Chen, Xiaoyan Lin, Yongsheng Wang, Jianan Huang, Jiuwei Cui, Lejie Cao, Yunpeng Liu, Yiping Zhang, Yueyin Pan, Jun Zhao, LiPing Wang, Jianhua Chang, Qun Chen, Xiubao Ren, Wei Zhang, Yun Fan, Zhiyong He, Jian Fang, Kangsheng Gu, Xiaorong Dong, Faguang Jin, Hongjun Gao, Guangyu An, Cuimin Ding, Xiaodong Jiang, Jianping Xiong, Xiangdong Zhou, Sheng Hu, Ping Lu, Anwen Liu, Shuliang Guo, Jianjin Huang, Chengchu Zhu, Jian Zhao, Beili Gao, Yinglan Chen, Chengping Hu, Jian Zhang, Hongmei Zhang, Hui Zhao, Yujie Zhou, Yanfei Tai
- Abstract
Loading...
-
+
EP1.04 - Immuno-oncology
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
EP1.04-40 - Extra-Thoracic Metastasis Indicated Worse Clinical Efficacy on Immune Checkpoint Inhibitors in Chinese Advanced NSCLC Patients
08:00 - 08:00 | Presenter: Sangtian Liu | Author(s): Anwen Xiong, Xuefei Li, Chao Zhao, Caicun Zhou
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-121 - Superior Outcomes of 1st Line EGFR TKI in Next-Generation Sequencing Identified Uncommon EGFR Exon 19delins Mutation Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Yongchang Zhang | Author(s): Nong Yang, Tao Jiang, Caicun Zhou
- Abstract
Loading... -
+
P1.01-22 - Investigation of Acquired Resistance for EGFR-TKI Plus Bevacizumab as 1st Line Treatment in Patients with EGFR Sensitive Mutant NSCLC
09:45 - 09:45 | Presenter: Yongchang Zhang | Author(s): Liang Zeng, Nong Yang, Tao Jiang, Caicun Zhou
- Abstract
Loading... -
+
P1.01-62 - Association of Baseline Pulmonary Fibrosis with the Outcome of PD-1 Inhibitor in Patients with Advanced Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Shiqi Mao | Author(s): Yiwei Liu, Fei Zhou, Anwen Xiong, Bin Chen, Guanghui Gao, Jia Yu, fengying Wu, Yayi He, Xiaoxia Chen, Chunxia Su, Shengxiang Ren, Caicun Zhou
- Abstract
Loading...
-
+
P1.03 - Biology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Biology
-
+
P1.03-50 - Type- and Stage-Specific Genomic Profiles in East Asian Lung Cancer Patients with No TKI-Related Driver Gene Mutations
09:45 - 09:45 | Presenter: Yayi He | Author(s): Xiaoxia Chen, Bin Chen, Lele Song, Xiaobin Li, Shifu Chen, Guifeng Liu, Caicun Zhou
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-46 - PD-1 Inhibitor Plus Chemotherapy as 2nd/Subsequent Line Setting Demonstrate Superior Efficacy Over PD-1 Inhibitor Alone in Pts of Advanced NSCLC
09:45 - 09:45 | Presenter: Shengxiang Ren | Author(s): Yiwei Liu, Fei Zhou, Tao Jiang, Chunxia Su, Xiaoxia Chen, Caicun Zhou
- Abstract
Loading... -
+
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-62 - Afatinib in EGFR TKI-Naïve Patients with EGFR Mutation-Positive NSCLC: Combined Analysis of Two Single-Arm Phase IIIb Studies
09:45 - 09:45 | Presenter: BJ Srinivasa | Author(s): Filippo De Marinis, Haiyan Tu, Konstantin Laktionov, Artem Poltoratskiy, Jun Zhao, Inna Egorova, Eng-Huat Tan, Maya Gottfried, Victor Lee, Dariusz Kowalski, Cheng-Ta Yang, Antonio Passaro, Laura Clementi, Wenbo Tang, Dennis Chin-Lun Huang, Agnieszka Cseh, Caicun Zhou, Yi-Long Wu
- Abstract
Loading...
-
+
MA11 - Immunotherapy in Special Populations and Predictive Markers
- 14:00 - 15:30
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:Frank Griesinger, Lecia Sequist
-
+
MA11.02 - KEYNOTE-042 China Study: First-Line Pembrolizumab vs Chemotherapy in Chinese Patients with Advanced NSCLC with PD-L1 TPS ≥1%
14:05 - 14:10 | Presenter: Yi-Long Wu | Author(s): Li Zhang, Yun Fan, Jianying Zhou, Li Zhang, Qing Zhou, Wei Li, ChengPing Hu, Gongyan Chen, Xin Zhang, Caicun Zhou, Thao Dang, Justina Penrod, Debra A. Kush, Yun Qin, Ben Li, Tony Mok
- Abstract
Loading... -
+
MA11.06 - A PII Study of Toripalimab, a PD-1 mAb, in Combination with Chemotherapy in EGFR+ Advanced NSCLC Patients Failed to Prior EGFR TKI Therapies
14:35 - 14:40 | Presenter: Jie Zhang | Author(s): Caicun Zhou, yanqiu Zhao, Xiaoqian Mu, Jianying Zhou, Zhang Bao, Yun Fan, Yanjun Xu, Yongqian Yong Shu, Renhua Guo, Xiaoqing Liu, Hong Wang, Helong Zhang, Lin Deng, Ningqiang Ma, Jianxing He, Yalei Zhang, mo Chen, Yinrui Jiang
- Abstract
Loading...